ALG-000184, a capsid assembly modulator, dosed with entecavir for up to 28 weeks is well tolerated and resulted in substantial declines in surface antigen levels in untreated Hepatitis B e antigen positive subjects with chronic hepatitis B
Saved in:
Published in | Journal of hepatology Vol. 78; pp. S112 - S113 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.06.2023
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0168-8278 |
---|---|
DOI: | 10.1016/S0168-8278(23)00600-1 |